The clinical management of chemotherapy-induced nausea and vomiting with adjuvant Progressive Muscle Relaxation Training (PMRT) and imagery techniques in breast cancer patients
| ISRCTN | ISRCTN27981153 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN27981153 |
| Protocol serial number | 811006 |
| Sponsor | Hong Kong Health Services Research Fund (China) |
| Funder | Hong Kong Health Services Research Fund (Hong Kong) |
- Submission date
- 10/10/2002
- Registration date
- 10/10/2002
- Last edited
- 05/10/2007
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr A Molassiotis
Scientific
Scientific
Nethersole School of Nursing
Chinese University of Hong Kong
-
-
Hong Kong
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Scientific title | |
| Study objectives | Not provided at time of registration |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Breast cancer |
| Intervention | PMRT 1 hour prior to chemotherapy administration and daily thereafter for another 5 days (total of 6 PMRT sessions). Each session lasts for 25 minutes followed by 5 minutes of imagery techniques. |
| Intervention type | Other |
| Primary outcome measure(s) |
Not provided at time of registration |
| Key secondary outcome measure(s) |
Not provided at time of registration |
| Completion date | 01/01/2001 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Lower age limit | 18 Years |
| Sex | Female |
| Key inclusion criteria | 1. Patients diagnosed with breast cancer and have no exposure to cytotoxic chemotherapeutic agent prior to the study (chemotherapy-naive) 2. Females between the age of 18 - 70 years 3. Clinical indication to receive adriamycin with cyclophosphamide (AC) as adjuvant or salvage chemotherapy for treatment of breast cancer 4. Able to read and write Chinese 5. Agree to sign the informed consent |
| Key exclusion criteria | Not provided at time of registration |
| Date of first enrolment | 01/01/1999 |
| Date of final enrolment | 01/01/2001 |
Locations
Countries of recruitment
- Hong Kong
Study participating centre
Nethersole School of Nursing
-
-
Hong Kong
-
Hong Kong
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | Results | 01/04/2002 | Yes | No |
